Suppr超能文献

[单相躁狂症:一种独特的实体还是躁狂优势的特征?]

[Unipolar mania: a distinct entity or characteristic of manic preponderance?].

作者信息

Yazıcı Olcay, Cakır Sibel

出版信息

Turk Psikiyatri Derg. 2012 Fall;23(3):201-5.

Abstract

OBJECTIVE

It has been reported that fewer patients with unipolar mania respond to lithium prophylaxis as do those with classical bipolar disorder. This study aimed to determine if the difference to response to lithium is related to unipolar mania or to a high preponderance of mania during the course of bipolarity.

MATERIALS AND METHODS

The study included bipolar-I patients (according to DSM-IV criteria) that had a ≥ 2-year history of either lithium or valproate prophylaxis as monotherapy. The response rate in the patients with unipolar mania and classical bipolar disorder were compared. Then, the response rate to lithium in all the patients with a manic episode rate <50% and >50%, and <80% and >80% during their course were compared. Finally, the above comparisons were repeated, excluding the patients with unipolar mania.

RESULTS

The study included 121 bipolar-I patients (34 unipolar mania and 87 classical bipolar disorder). The response rate to lithium prophylaxis was significantly lower in the unipolar mania group than that in the bipolar group, whereas, the response rate to valproate prophylaxis was similar in both groups. Additionally, significantly fewer patients with a manic episode rate >80% during their course responded to lithium, followed by those with a manic episode rate >50%; however, these differences disappeared when the unipolar mania group was excluded from the comparison.

CONCLUSION

Fewer patients with unipolar mania responded to lithium prophylaxis than those with classical bipolar disorder, which appeared to be related to unipolar mania, rather than to a high manic predominance during the disease course. On the other hand, response to valproate prophylaxis was similar in the unipolar mania and classical bipolar disorder groups.

摘要

目的

据报道,与典型双相情感障碍患者相比,单相躁狂症患者对锂盐预防性治疗的反应较少。本研究旨在确定对锂盐反应的差异是与单相躁狂症有关,还是与双相情感障碍病程中躁狂发作的高占比有关。

材料与方法

该研究纳入了符合DSM-IV标准的双相I型患者,这些患者有≥2年的锂盐或丙戊酸盐单一疗法预防性治疗史。比较单相躁狂症患者和典型双相情感障碍患者的缓解率。然后,比较所有躁狂发作率在病程中<50%和>50%,以及<80%和>80%的患者对锂盐的缓解率。最后,重复上述比较,但排除单相躁狂症患者。

结果

该研究纳入了121例双相I型患者(34例单相躁狂症患者和87例典型双相情感障碍患者)。单相躁狂症组对锂盐预防性治疗的缓解率显著低于双相情感障碍组,而两组对丙戊酸盐预防性治疗的缓解率相似。此外,病程中躁狂发作率>80%的患者对锂盐有反应的明显较少,其次是躁狂发作率>50%的患者;然而,当在比较中排除单相躁狂症组时,这些差异消失了。

结论

与典型双相情感障碍患者相比,单相躁狂症患者对锂盐预防性治疗的反应较少,这似乎与单相躁狂症有关,而不是与疾病病程中躁狂发作占主导有关。另一方面,单相躁狂症组和典型双相情感障碍组对丙戊酸盐预防性治疗的反应相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验